Cape Investment Advisory’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-63
Closed -$6.62K 1216
2025
Q1
$6.62K Hold
63
﹤0.01% 682
2024
Q4
$6.75K Hold
63
﹤0.01% 670
2024
Q3
$6.31K Hold
63
﹤0.01% 657
2024
Q2
$5.31K Buy
+63
New +$5.31K ﹤0.01% 650